Cabaletta Bio Inc expected to post a loss of 65 cents a share - Earnings Preview

Cabaletta Bio

04/08/2025 15:11

Cabaletta Bio Inc CABA.OQ CABA.O is expected to  show a rise in quarterly revenue when it reports  results on August 6 (estimated) for the period ending June 30 2025

The Philadelphia Pennsylvania-based  company is expected to report revenue of $4.167 million, according to the mean estimate from 6 analysts, based on LSEG data.

‚ÄčLSEG's mean analyst estimate for Cabaletta Bio Inc is for a loss of 65 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ‚Äč

Wall Street's median 12-month price target for Cabaletta Bio Inc is $15.00, about 90.4% above its last closing price of $1.44

Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč

QUARTER ENDING
STARMINESMARTESTIMATE¬ģ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2025
-0.64
-0.64
-0.71
Missed
-10.4
Dec. 31 2025
-0.63
-0.65
Missed
-3
Sep. 30 2024
-0.59
-0.60
-0.62
Missed
-4‚Äč
Jun. 30 2024
-0.56
-0.55
-0.56
Missed
-2.2
‚Äč‚ÄčMar. 31 2024
-0.47
-0.48
-0.51
Missed
-7.2
Dec. 31 2023
-0.40
-0.39
-0.46
Missed
-17.2‚Äč
Sep. 30 2023
-0.41
-0.40
-0.37
Beat
8.3
Jun. 30 2023
-0.44
-0.44
-0.37
Beat
16.4

This summary was machine generated August 4 at 14:11 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)